Sravan Kumar Emany - 24 Feb 2026 Form 3 Insider Report for Kyverna Therapeutics, Inc. (KYTX)

Role
Director
Signature
/s/ Marc Grasso, as Attorney-in-Fact
Issuer symbol
KYTX
Transactions as of
24 Feb 2026
Net transactions value
$0
Form type
3
Filing time
26 Feb 2026, 16:30:03 UTC
Previous filing
02 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Emany Sravan Kumar Director C/O KYVERNA THERAPEUTICS, INC., 5980 HORTON ST., STE 550, EMERYVILLE /s/ Marc Grasso, as Attorney-in-Fact 26 Feb 2026 0001897662

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney